These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34509129)

  • 1. Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms.
    Shimomura Y; Kikuchi Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
    Schizophr Res; 2021 Oct; 236():142-155. PubMed ID: 34509129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
    Shimomura Y; Kikuchi Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
    Schizophr Res; 2020 Jan; 215():8-16. PubMed ID: 31784340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms.
    Takeuchi H; Suzuki T; Uchida H; Watanabe K; Mimura M
    Schizophr Res; 2012 Feb; 134(2-3):219-25. PubMed ID: 22154594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
    Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
    J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
    Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
    Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation.
    Howes OD; Vergunst F; Gee S; McGuire P; Kapur S; Taylor D
    Br J Psychiatry; 2012 Dec; 201(6):481-5. PubMed ID: 22955007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.
    McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ
    BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.
    Martínez-Andrés JA; García-Carmona JA
    Int Clin Psychopharmacol; 2020 May; 35(3):163-169. PubMed ID: 31851035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine versus typical neuroleptic medication for schizophrenia.
    Wahlbeck K; Cheine M; Essali MA
    Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Feb; 73(2):e07. PubMed ID: 22401484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
    de Bartolomeis A; Ciccarelli M; Vellucci L; Fornaro M; Iasevoli F; Barone A
    Expert Opin Pharmacother; 2022 Dec; 23(18):2035-2052. PubMed ID: 36368055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine prescribing barriers in the management of treatment-resistant schizophrenia: A systematic review.
    Baig AI; Bazargan-Hejazi S; Ebrahim G; Rodriguez-Lara J
    Medicine (Baltimore); 2021 Nov; 100(45):e27694. PubMed ID: 34766570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.
    Miller A; Hall CS; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Ereshefsky L; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Rush AJ; Saeed SA; Schooler NR; Shon SP; Stroup S; Tarin-Godoy B
    J Clin Psychiatry; 2004 Apr; 65(4):500-8. PubMed ID: 15119912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone versus other atypical antipsychotic medication for schizophrenia.
    Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
    Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.